Michael joined IMARC after working for eight years in the laboratory of Hisashi Tanaka in the Department of Molecular Genetics at the Cleveland Clinic Foundation. While at the Cleveland Clinic, he worked on evaluating the role of palindromes in gene amplification and the implications on tumor development, pathogenesis, drug resistance, and genome variation/evolution. While there he received his Masters of Science in Biology for development and testing of lethal mutagenesis as an antiviral strategy against HIV-1. He has had the opportunity to present his work at both National and Local Scientific Conferences, publish his results in leading scientific journals, and his research has been funded by the National Institute of Health.
Michael joined IMARC in February 2014 and has monitored studies investigating treatments for thoracic aneurysms/ulcers, internal iliac artery patency, acute MI diagnostics, peripheral arterial disease, osteoarthritis, articular cartilage defects, benign prostatic hyperplasia, and rotator cuff tears. His diverse background in working in a wide array of scientific fields, large datasets, and utilizing innovative approaches to tackle complex diseases has aided him in tackling new projects and providing fresh insight when monitoring clinical studies. His ability to distill complex information into simple concepts allows him to work well with sites to follow challenging protocols. Studies that Michael has worked on have received FDA approval, and he has interacted with several sites that have undergone FDA inspections with no findings.
In 2016 Michael became a Lead Clinical Research Associate and as a Lead CRA he has been able to coordinate the training and activities of the monitor teams in order to ensure compliance with the overall study objectives. At the conclusion of 2016, Michael became a Manager of Clinical Monitoring Services. Within this position he works closely with and supervises CRAs at IMARC to ensure that the high quality of monitoring continues that Sponsors have come to expect from IMARC. When he is not monitoring clinical trials, Michael enjoys providing training to new CRAs, sites, and Sponsors and staying current on new trends in medical devices, personalized medicine, and FDA Guidances.
Michael received both his Masters Degree and Undergraduate Degree in Biology at John Carroll University in University Heights, Ohio.